Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02724683|
Recruitment Status : Recruiting
First Posted : March 31, 2016
Last Update Posted : April 5, 2019
|Condition or disease||Intervention/treatment|
|Malignant Ascites||Device: Ascites drainage with vascular catheter. Behavioral: Interview. Behavioral: Quality of life. Device: Quality of procedure. Other: Nutritional status|
Patients with symptomatic, refractory malignant ascites (MA) will be eligible for the study. In case a cancer treatment is not effective against ascites, or no target, systemic treatment is possible patients will be eligible for percutaneous placement of a vascular catheter into abdominal cavity followed be drainage performed in a regular basis when required, at home or ambulatory. Adult patients with every malignant disease, female and male, and coexisting symptomatic MA can be recruited.
Clinical, quality of life (QOL) and quality of the procedure data will be collected. The study is planned to be a multiinstitutional. A template is provided to collect essential clinical data concerned with a patient, malignant disease, procedure performance and complications. QOL and patients' experience on the treatment is to be evaluated with formal questionnaires - EORTC C15-PAL and FACIT-TS-G - permission to use granted from EORTC and FACIT respectively. Additionally, a nutrition monitoring will be performed (if possible and feasible) in patients with MA and drainage.
Data will be saved in a computer, secured data base for calculations. A cohort of 150 patients is planned to be collected. Duration of the study will depend on how many institutions will participate, and how fast patients will be recruited.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||170 participants|
|Target Follow-Up Duration:||2 Weeks|
|Official Title:||Management of Symptomatic Malignant Ascites With an Patient-controlled, Vascular Catheter - a Validation Study.|
|Study Start Date :||January 2016|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||June 2020|
Symptomatic ascites drainage with CVC.
Patients with malignant, symptomatic, refractory ascites. Ascites drainage with vascular catheter (CVC) inserted into abdominal cavity will be performed. Patients will be asked to complete interview, quality of life questionnaire, nutritional status assessment and quality of procedure survey.
Device: Ascites drainage with vascular catheter.
In case of symptomatic malignant ascites, the procedure of vascular catheter insertion into abdominal cavity will be performed, followed by slow, systematic drainage, on patient's demand.
Interview with patients will be performed according to attached chart. The aim is to collect data concerning patient's symptoms, co-morbidity, and basic clinical data about the primary malignancy and treatment status.
Behavioral: Quality of life.
Quality of life questionnaire (QLQ). Patients will be asked to complete QLQ at two time points: 1. immediately before the procedure, 2. one or two weeks after the procedure.
Device: Quality of procedure.
Patients will be asked to complete quality of procedure questionnaire at one time point: one or two weeks after the procedure.
Other: Nutritional status
Risk of malnutrition and ability to feed normally will be assessed with specific questionnaire at two time points: 1. immediately before the procedure, 2. one or two weeks after the procedure.
- Number of participants with adverse events. [ Time Frame: 2 weeks ]Early and late adverse events of the catheter placement and later drainage to be recorded.
- Change in quality of life. [ Time Frame: 2 weeks ]Change in quality of life measured with standard questionnaire EORTC-C15-PAL before the procedure and 1-2 weeks later.
- Number of participants with drainage complication during cancer treatment vs observation. [ Time Frame: 1 month ]Assessment of possibilities to provide cancer treatment with active ascites drainage via catheter, by reporting number of participants with adverse events during chemotherapy or radiotherapy, whichever applies and comparison to observation (patients with palliative intent only, no active cancer treatment).
- Number of participants with successful catheter placement. [ Time Frame: 2 weeks ]From all eligible participants a number of participants with successful catheter placement followed by effective drainage will be recorded.
- Patient's experience on the treatment. [ Time Frame: 2 weeks ]Patient's experience on the treatment measured with standard questionnaire (FACIT-TS-G).
- Change in nutrition habits. [ Time Frame: 2 weeks ]Changes in ability to feed assessed in a descriptive way with the Subjective Global Assessment (SGA) questionnaire.
- Change in nutrition status among participants with prolonged ascites drainage. [ Time Frame: 1 month ]Risk of malnutrition and ability to feed normally to be assessed with Subjective Global Assessment (SGA) questionnaire among participants with prolonged (1-2 months) ascites drainage.
- Number of ambulatory visits or hospital admissions. [ Time Frame: 1 month ]Number of ambulatory visits or hospital admissions to manage symptoms caused by ascites.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02724683
|Contact: Maciej Stukan, MDfirstname.lastname@example.org|
|Gdynia Oncology Center||Recruiting|
|Gdynia, Poland, 81-519|
|Contact: Maciej Stukan, MD +48692112481 email@example.com|
|Principal Investigator:||Maciej Stukan, MD||Gdynia Oncology Center|